Document Detail


Incidence of factor V Leiden in patients with acute myocardial infarction.
MedLine Citation:
PMID:  10590188     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The genetic defect of coagulation factor V known as factor V Leiden produces a resistance to degradation by activated protein C (APC) and increases the risk of venous thromboembolism. The data on arterial thrombosis associated with APC resistance are still not clearly defined. We conducted a study in patients presenting with acute myocardial infarction (MI) to assess whether factor V Leiden increases the risk of arterial thrombosis. We studied 109 patients who had a diagnosis of acute MI (69 males and 40 females, aged 25-91 years), and 112 controls. The study population was identified by characteristic ECG changes and elevation of serum CK-MB, whereas the control subjects were anonymous healthy blood donors with no known history of coronary artery disease. Blood samples from the patients and controls were analyzed for the factor V Leiden mutation by DNA analysis, using the polymerase chain reaction. Heterozygous factor V Leiden mutation was found in 9 of 109 (8%) MI patients and 5 of 112 (4%) control subjects (P =.42). In conclusion, this study shows no evidence of an association between factor V Leiden and acute MI.
Authors:
M S Gowda; M L Zucker; J L Vacek; W L Carriger; D L Van Laeys; J M Rachel; B D Strope
Related Documents :
18685428 - Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treate...
1331348 - Postoperative venous thromboembolism and brain tumors: part i. clinical profile.
15824368 - Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weig...
17549288 - Circulating p-selectin and the risk of recurrent venous thromboembolism.
2920258 - Bladder replacement by ileocaeco-urethrostomy or ileo-urethrostomy with a reservoir aft...
1700808 - Dystrophin immunostaining in muscles from patients with different types of muscular dys...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of thrombosis and thrombolysis     Volume:  9     ISSN:  0929-5305     ISO Abbreviation:  J. Thromb. Thrombolysis     Publication Date:  2000 Jan 
Date Detail:
Created Date:  2000-03-01     Completed Date:  2000-03-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9502018     Medline TA:  J Thromb Thrombolysis     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  43-5     Citation Subset:  IM    
Affiliation:
University of MissouriKansas City, Mid America Heart Institute and Department of Pathology, St. Lukes Hospital, Kansas City, Missouri, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activated Protein C Resistance
Adult
Aged
Aged, 80 and over
Cohort Studies
Factor V / genetics*
Female
Heterozygote
Humans
Incidence
Male
Middle Aged
Myocardial Infarction / blood,  etiology,  genetics*
Point Mutation
Polymerase Chain Reaction
Chemical
Reg. No./Substance:
0/factor V Leiden; 9001-24-5/Factor V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of short-term aspirin use on C-reactive protein.
Next Document:  Prevention of left ventricular remodeling by percutaneous transluminal coronary angioplasty performe...